COVID-19 Alert for Cancer Patients

The Vanderbilt-Ingram Cancer Center is following the COVID-19 pandemic closely and taking steps to protect our patients and our staff. Please be assured that we are here for you.

Updated September 11, 2020

VICC COVID-19 Newsletter

We will be diligently updating information on a regular basis for specific diseases and conditions.

For cancer info, click here.
Para más información en Español sobre cáncer visite la siguiente página.

For the latest info about coronavirus for VUMC patients and visitors.

For the latest VUMC restricted visitor policy.

Partners in Discovery

Vanderbilt-Ingram Cancer Center

Vanderbilt-Ingram Cancer Center is at the forefront of new discoveries that help us prevent, find, treat, manage and cure cancer. But we can't make these discoveries alone. Our patients, caregivers, community leaders, donors, volunteers, and educators contribute their insight, time, and passion to advancing the discoveries that lead us closer to a cure.

No matter how cancer has touched your life, you are a key partner in our efforts to save lives and improve the quality of life for those with cancer.

_{Harnessing the power of

science for our patients}

_{Our doctors and researchers are turning today's}
_{scientific discoveries into tomorrow's treatments.}
_{Learn more about our research programs and initiatives.}

Research Programs

Specialized Programs of Research Excellence (SPOREs)

Research Centers & Initiatives

Proven Track Record

A leader in research, innovation and treatment. We are one of 51 National Cancer Institute-designated Comprehensive Cancer Centers, dedicated to an integrated and patient-focused approach.

Patients, Partners, Progress

Our patients and families are our most important partners in discovery – and the motivation behind our efforts to advance research and improve cancer care.

Read their stories from Momentum magazine.

Learn More

We’ve Only Just Begun

Facing cancer with youthful resilience

Pay it Forward

Bladder cancer research fund honors mentor

Blazing a new trail

Clinical trial participant forges a different treatment path

Rini to lead NCI study of COVID-19 in cancer patients

Brian Rini, MD, is leading a study launched by NCI that will closely monitor cancer patients who acquire COVID-19 with the goal of providing highly detailed data to guide future care.

Lovly to chair foundation’s scientific leadership board

Christine Lovly, MD, PhD, Ingram Associate Professor of Cancer Research, has been named incoming chair of GO2 Foundation’s Scientific Leadership Board (SLB).

Park named director of Hematology and Oncology at VICC

After serving as interim director since Jan. 1, Ben Ho Park, MD, PhD, has been named director of the Division of Hematology and Oncology.

‘Black in Cancer’ promotes diversity in research

Black In Cancer, an initiative cofounded by Henry Henderson III, PhD, a postdoctoral researcher at Vanderbilt-Ingram Cancer Center, is making an impact just two months after its inception.

VICC receives ‘exceptional’ score with renewal as an NCI-Designated Comprehensive Cancer Center

VICC received an overall “exceptional” score for its research impact and excellence in patient care. This achievement merits renewed funding from the NCI and places it once again in a top group of NCI Comprehensive Cancer Centers.

Cancer centers nationwide join to address the impact of COVID-19 pandemic on cancer prevention and treatment

A consortium of 17 cancer centers in the United States, including VICC, have come together to better understand the consequences of the COVID-19 pandemic in delaying cancer detection, care and prevention.